Docket
118th Congress · HOUSE BILLBILL

H.R. 7535 — Prescription Drug Supply Chain Pricing Transparency Act

“To require the Comptroller General of the United States to conduct a study and submit a report on price-related compensation and payment structures in the prescription drug supply chain.”

Health
Introduced Mar 5, 2024
Last action Dec 17, 2024
Pipeline · Bill → Law
Step 1
Introduced
Mar 5, 2024
Step 2
Referred
Dec 17, 2024
E&C · Ways & Means
Step 3
Committee
Step 4
House floor
Step 5
Senate
Step 6
Resolve Changes
Step 7
Signed
SummaryNo summary available

No CRS summary available for this bill.

Provisions · 2 sectionsIntroduced in House
Timeline · 5 actions
Dec 17, 2024
Referred to the Subcommittee on Health.
Mar 8, 2024
Referred to the Subcommittee on Health.
Mar 5, 2024
Introduced in House
Mar 5, 2024
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Mar 5, 2024
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.